Time and cost involved in measuring access to medicines: the case of Albania

被引：0
|
作者：
E. Petro [1 ]
I. R. Joosse [2 ]
A. C. M. Siebers [2 ]
T. Martopullo [2 ]
R. P. M. Hart [3 ]
A. K. Mantel-Teeuwisse [2 ]
H. A. van den Ham [2 ]
F. Suleman [2 ]
机构：
[1] Local Healthcare Unit,WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS)
[2] Utrecht University,WHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, Discipline of Pharmaceutical Sciences, School of Health Sciences
[3] Lady of Good Counsel University,undefined
[4] University of KwaZulu-Natal,undefined
来源：
BMC Research Notes | / 18卷 / 1期
关键词：
Access to medicines; Cost expenditures; Data collection; Essential medicines; Monitoring tools; Research methodology; Albania;
D O I：
10.1186/s13104-025-07168-5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Clearing the air: towards agreement about access to high cost cancer medicines
    Lipworth, W.
    Kerridge, I.
    Ghinea, N.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 143 - 146
  • [32] Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis
    Sruamsiri, Rosarin
    Wagner, Anita K.
    Ross-Degnan, Dennis
    Lu, Christine Y.
    Dhippayom, Teerapon
    Ngorsuraches, Surachat
    Chaiyakunapruk, Nathorn
    BMJ OPEN, 2016, 6 (03):
  • [33] Corporate social responsibility to improve access to medicines: the case of Brazil
    Thorsteinsdottir, Halla
    Ovtcharenko, Natasha
    Kohler, Jillian Clare
    GLOBALIZATION AND HEALTH, 2017, 13
  • [34] Gender Differences in Early Access to Medicines: The Case of Diabetes Trials
    Bazargani, Yaser T.
    deBoer, Anthonius
    Leufkens, Hubert G. M.
    Mantel-Teeuwisse, Aukje
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 67 - 67
  • [35] Intellectual property and access to medicines: the case of lopinavir/ritonavir in Guatemala
    Pablo Mendez-Alburez, Luis
    Ceron, Alejandro
    SALUD PUBLICA DE MEXICO, 2016, 58 (06): : 587 - 588
  • [36] Measuring affordability of access to clean water: A coping cost approach
    Amit, R. K.
    Sasidharan, Subash
    RESOURCES CONSERVATION AND RECYCLING, 2019, 141 : 410 - 417
  • [37] The cost of shopping: measuring virtual and physical access for obtaining goods
    Chen, Jing
    Cui, Mengying
    Levinson, David
    TEMA-JOURNAL OF LAND USE MOBILITY AND ENVIRONMENT, 2024, 17 (01) : 129 - 145
  • [38] Malaria, medicines and miles: A novel approach to measuring access to treatment from a household perspective
    Palafox, Benjamin
    Goodman, Catherine
    Hanson, Kara
    SSM-POPULATION HEALTH, 2019, 7
  • [39] Measuring the cost of restricting access to cropland for manure nutrient management
    Fleming, RA
    Long, JD
    AGRONOMY JOURNAL, 2002, 94 (01) : 57 - 64
  • [40] Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme
    Shroufi, Amir
    Govender, Nelesh P.
    Meintjes, Graeme
    Black, John
    Nel, Jeremy
    Moosa, Mahomed-Yunus S.
    Menezes, Colin
    Dawood, Halima
    Wilson, Douglas
    Duran, Laura Trivino
    Ajose, Olawale
    Murphy, Richard A.
    Harrison, Thomas
    Loyse, Angela
    Ruffell, Carol
    Van Cutsem, Gilles
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95 : 459 - 461
12345